Alzheimer's Association
110
25
31
61
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 45/100
5.5%
6 terminated/withdrawn out of 110 trials
91.0%
+4.5% vs industry average
5%
6 trials in Phase 3/4
23%
14 of 61 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (110)
Rapamycin - Effects on Alzheimer's and Cognitive Health
Role: collaborator
Lifestyle Interventions for the Treatment of Early Onset Alzheimer's Disease Study
Role: collaborator
LatAm-FINGERS Initiative for Cognitive Change
Role: collaborator
Phase II Trial to Evaluate Safety and Efficacy of GM-CSF/Sargramostim in Alzheimer's Disease
Role: collaborator
Inspiring Seniors Towards Exercise Promotion to Protect Cognition
Role: collaborator
Evaluating a National Person-Centered Training Program to Strengthen the Dementia Care Workforce
Role: collaborator
A Novel VIRTUAL Reality Intervention for CAREgivers of People With Dementia (VirtualCare)
Role: collaborator
Valacyclovir for Mild Cognitive Impairment
Role: collaborator
Olfactory Training in Mild Cognitive Impairment
Role: collaborator
Allopregnanolone Regenerative Therapeutic for Early Alzheimer's Disease: Intramuscular Study
Role: collaborator
Multimodal Investigation of Neural Plasticity
Role: collaborator
Nicotinic Acid for the Treatment of Alzheimer's Disease
Role: collaborator
DIAN-TU Amyloid Removal Trial (ART) in Dominantly Inherited Alzheimer's Disease
Role: collaborator
Dementia and Storytelling in Vietnam
Role: collaborator
Longitudinal Early-onset Alzheimer's Disease Study Protocol
Role: collaborator
A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Role: collaborator
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation (DIAN-TU)
Role: collaborator
A Study of a Potential Disease Modifying Treatment in Individuals at Risk for or With a Type of Early Onset AD Caused by a Genetic Mutation
Role: collaborator
Dominantly Inherited Alzheimer Network Trial: An Opportunity to Prevent Dementia. A Study of Potential Disease Modifying Treatments in Individuals at Risk for or With a Type of Early Onset Alzheimer's Disease Caused by a Genetic Mutation. Master Protocol DIAN-TU-001
Role: collaborator
Advancing Alzheimer's Care: Home-based tDCS for Affective Symptoms
Role: collaborator